20:36:42 EDT Tue 21 May 2024
Enter Symbol
or Name
USA
CA



Perimeter Medical Imaging AI Inc
Symbol PINK
Shares Issued 64,467,701
Close 2023-05-18 C$ 1.92
Market Cap C$ 123,777,986
Recent Sedar Documents

Perimeter Medical to release Q1 2023 results May 25

2023-05-18 16:38 ET - News Release

An anonymous director reports

PERIMETER MEDICAL IMAGING AI ANNOUNCES CONFERENCE CALL AND WEBCAST TO DISCUSS FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE

Perimeter Medical Imaging AI Inc. will release its first quarter 2023 financial and operating results after the close of U.S. financial markets on Thursday, May 25, 2023.

Conference call/webcast information

Date: Thursday, May 25, 2023

Time: 5 p.m. Eastern Time

Dial-in number: 1-877-704-4453

International dial-in: 1-201-389-0920

Conference ID: 13738979

Presenter: Jeremy Sobotta, chief executive officer

The conference call will also be broadcast live on-line through a listen-only webcast, which will be posted on the investors section of the company's website. The webcast will be archived on the company's investor relations web page for at least 90 days. A telephonic playback of the conference call will be available for 14 days after the conference call by calling 1-844-512-2921 or 1-412-317-6671 from abroad and referencing conference ID 13738979. The above listed dates and times are subject to change.

About Perimeter Medical Imaging AI Inc.

Based in Toronto, Canada, and Dallas, Tex., Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultrahigh-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the United States, its Food and Drug Administration-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents Perimeter's next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to $7.4-million (U.S.) awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol PINK is a reference to the pink ribbons used during Breast Cancer Awareness Month.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.